Biotech AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team October 1, 2024
Biotech Revolutionary lab-grown lung tissue set to transform therapies for respiratory diseases and organ transplantation October 1, 2024
Biotech NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics September 30, 2024
Biotech MSD in Strategic collaboration with Briya for Innovative RWE data analysis projects September 30, 2024
Biotech Multiple Study Results of Kelun-Biotech’s TROP2-ADC SKB264 (sac-TMT) at 2024 CSCO Congress September 29, 2024
Biotech AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer September 28, 2024
Biotech Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients September 28, 2024